Swiss National Bank
STOK icon

Swiss National Bank’s Stoke Therapeutics STOK Stock Holding History

Swiss National Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Sell
74,200
-4,900
-6% -$157K ﹤0.01% 1838
2026
Q1 		$2.58M Buy
79,100
+3,400
+4% +$112K ﹤0.01% 1726
2025
Q4 		$2.4M Buy
75,700
+1,600
+2% +$48.1K ﹤0.01% 1784
2025
Q3 		$1.74M Buy
74,100
+12,100
+20% +$207K ﹤0.01% 1922
2025
Q2 		$704K Sell
62,000
-5,300
-8% -$50.3K ﹤0.01% 2254
2025
Q1 		$448K Hold
67,300
– – ﹤0.01% 2356
2024
Q4 		$742K Buy
67,300
+11,400
+20% +$140K ﹤0.01% 2324
2024
Q3 		$687K Sell
55,900
-10,500
-16% -$149K ﹤0.01% 2356
2024
Q2 		$897K Buy
+66,400
New +$897K ﹤0.01% 2216
2023
Q4 		– Sell
-43,300
Closed -$171K – 2603
2023
Q3 		$171K Hold
43,300
– – ﹤0.01% 2605
2023
Q2 		$460K Buy
43,300
+9,200
+27% +$97.9K ﹤0.01% 2549
2023
Q1 		$284K Sell
34,100
-3,100
-8% -$28K ﹤0.01% 2615
2022
Q4 		$343K Hold
37,200
– – ﹤0.01% 2637
2022
Q3 		$478K Buy
37,200
+2,400
+7% +$38.2K ﹤0.01% 2585
2022
Q2 		$460K Buy
34,800
+4,300
+14% +$65.3K ﹤0.01% 2631
2022
Q1 		$642K Buy
30,500
+2,300
+8% +$46.1K ﹤0.01% 2543
2021
Q4 		$677K Hold
28,200
– – ﹤0.01% 2593
2021
Q3 		$717K Hold
28,200
– – ﹤0.01% 2518
2021
Q2 		$949K Buy
28,200
+7,600
+37% +$269K ﹤0.01% 2500
2021
Q1 		$800K Buy
20,600
+1,800
+10% +$102K ﹤0.01% 2395
2020
Q4 		$1.16M Sell
18,800
-3,100
-14% -$142K ﹤0.01% 2220
2020
Q3 		$733K Hold
21,900
– – ﹤0.01% 2247
2020
Q2 		$522K Buy
21,900
+6,300
+40% +$150K ﹤0.01% 2373
2020
Q1 		$357K Hold
15,600
– – ﹤0.01% 2302
2019
Q4 		$442K Buy
+15,600
New +$392K ﹤0.01% 2447

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Swiss National Bank's STOK Position: Q2 2026 in Review

Swiss National Bank reduced its Stoke Therapeutics (STOK) stake by 6.2% in Q2 2026, selling an estimated $157K and leaving 74,200 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Swiss National Bank first reported a position in STOK in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.58M in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Swiss National Bank held 74,200 shares of Stoke Therapeutics worth $2.43M as of Q2 2026.
  • Swiss National Bank sold 4,900 Stoke Therapeutics shares in Q2 2026, an estimated $157K.
  • Stoke Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1838 holding.
  • Swiss National Bank first reported a position in Stoke Therapeutics in Q4 2019 and has held it in 25 quarters since.
  • Swiss National Bank's Stoke Therapeutics position peaked at $2.58M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.